Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

88.13
-0.6400-0.72%
Volume:214.26K
Turnover:18.94M
Market Cap:22.12B
PE:-15.97
High:89.34
Open:87.89
Low:87.70
Close:88.77
52wk High:124.00
52wk Low:79.52
Shares:251.00M
Float Shares:105.00M
Volume Ratio:0.24
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.5189
EPS(LYR):-5.5184
ROE:-5.88%
ROA:-3.56%
PB:1.00
PE(LYR):-15.97

Loading ...

BioNTech SE ADR Climbs 4.9%, Outperforms Market

Dow Jones
·
Jan 14

BioNTech outlines 2026 areas of focus

TIPRANKS
·
Jan 12

BioNTech Maps Out Catalyst-Rich 2026 Oncology Agenda at J.P. Morgan Healthcare Conference

TIPRANKS
·
Jan 12

Biontech Expects At Least 17 Data Publications From Clinical Trials In Late-Stage Development Over Next Five Years

Reuters
·
Jan 12

BioNTech Raises 2025 Revenue Outlook to €2.6–2.8 Billion and Signals Modest Decline for 2026

Reuters
·
Jan 12

FDA Grants Orphan-Drug Status to BioNTech's Gotistobart for Lung Cancer

Reuters
·
Jan 12

Net Insight Names CCO Andreas Eriksson as New CEO to Lead Next Growth Phase

TIPRANKS
·
Jan 12

BioNTech SE Launches $50 Million Life Sciences Fund With University of Pennsylvania and OUP

Reuters
·
Jan 09

Bayer sues COVID vaccine makers over mRNA technology

Reuters
·
Jan 07

Billionaire Andreas Halvorsen Loads Up On Chewy — Is Smart Money Calling A CHWY Bottom?

Benzinga_recent_news
·
Jan 07

BUZZ-U.S. STOCKS ON THE MOVE-Nike, silver and gold miners, Vanda Pharma, Tesla

Reuters
·
Dec 31, 2025

BUZZ-Vaccine makers end the year in red

Reuters
·
Dec 31, 2025

Genmab scraps development of experimental cancer therapy

Reuters
·
Dec 29, 2025

Biontech Closes Acquisition Of CureVac

Reuters
·
Dec 18, 2025

BioNTech Closes Acquisition of CureVac

Reuters
·
Dec 18, 2025

Andon Health Gets US Approval for Flu, COVID-19, RSV Test Kits

MT Newswires Live
·
Dec 15, 2025

Berenberg Raises Price Target on BioNTech to $155 From $150, Keeps Buy Rating

MT Newswires Live
·
Dec 11, 2025

U.S. RESEARCH ROUNDUP-BioNTtech, GE Vernova, Synopsys

Reuters
·
Dec 11, 2025

BioNTech Se : Berenberg Raises Target Price to $155 From $150

THOMSON REUTERS
·
Dec 11, 2025

Debate On Vaccine Safety Reaches Policy Stage - FDA Broadens Review Into Covid-19 Shot Risks In Adults

Benzinga
·
Dec 10, 2025